Enrique Carrazana

2012

In 2012, Enrique Carrazana earned a total compensation of $1.2M as Chief Medical Officer at Acorda Therapeutics.

Compensation breakdown

Bonus$50,000
Non-Equity Incentive Plan$155,230
Option Awards$343,588
Salary$365,667
Stock Awards$213,435
Other$62,569
Total$1,190,489

Carrazana received $365.7K in salary, accounting for 31% of the total pay in 2012.

Carrazana also received $50K in bonus, $155.2K in non-equity incentive plan, $343.6K in option awards, $213.4K in stock awards and $62.6K in other compensation.

Rankings

In 2012, Enrique Carrazana's compensation ranked 5,468th out of 11,487 executives tracked by ExecPay. In other words, Carrazana earned more than 52.4% of executives.

ClassificationRankingPercentile
All
5,468
out of 11,487
52nd
Division
Manufacturing
1,924
out of 4,253
55th
Major group
Chemicals And Allied Products
463
out of 1,198
61st
Industry group
Drugs
306
out of 920
67th
Industry
Biological Products, Except Diagnostic Substances
54
out of 160
66th
Source: SEC filing on April 30, 2015.

Carrazana's colleagues

We found four more compensation records of executives who worked with Enrique Carrazana at Acorda Therapeutics in 2012.

2012

Ron Cohen

Acorda Therapeutics

Chief Executive Officer

2012

Jane Wasman

Acorda Therapeutics

General Counsel

2012

Andrew Blight

Acorda Therapeutics

Chief Scientific Officer

2012

David Lawrence

Acorda Therapeutics

Chief Financial Officer

You may also like